Legend Biotech Overview
Legend Biotech Target Price
Analysts' 12-month price predictions for LEGN.
Get informed when a big investor buys or sells
+ FollowShare Price
$25.67
Average Target Price
$56.50
120.1% upside
120.1% upside6 analysts in the last 4 months
High: $65 | Low: $48
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-07 | RBC CapitalLeonid Timashev | $63 | 145.4% upside |  |
| 2026-06-03 | UBSAshwani Verma | $49 | 90.9% upside | |
| 2026-06-03 | H.C. Wainwright | $65 | 153.2% upside | |
| 2026-06-01 | UBS | $50 | 94.8% upside | |
| 2026-05-13 | RBC CapitalLeonid Timashev | $64 | 149.3% upside | |
| 2026-05-13 | Morgan StanleyTerence Flynn | $48 | 87% upside | |
| 2026-03-11 | Morgan Stanley | $49 | 90.9% upside | |
| 2026-03-11 | RBC Capital | $62 | 141.5% upside | |
| 2026-03-10 | Truist FinancialAsthika Goonewardene | $70 | 172.7% upside | |
| 2026-03-10 | JefferiesCui Cui | $69 | 168.8% upside | |
| 2026-02-12 | Redburn PartnersQize Ding | $24 |  6.5% downside | |
| 2026-01-22 | H.C. Wainwright | $50 | 94.8% upside | |
| 2026-01-22 | Jefferies | $21 | 18.2% downside | |
| 2026-01-20 | RBC Capital | $66 | 157.1% upside | |
| 2026-01-07 | Oppenheimer | $75 | 192.2% upside | |
| 2025-12-17 | Cantor Fitzgerald | $74 | 188.3% upside | |
| 2025-12-12 | Morgan Stanley | $50 | 94.8% upside | |
| 2025-12-08 | RBC CapitalLeonid Timashev | $74 | 188.3% upside | |
| 2025-12-08 | UBSAshwani Verma | $48 | 87% upside | |
| 2025-10-17 | Johnson Rice | $60 | 133.7% upside | |
| 2025-07-02 | UBSAshwani Verma | $54 | 110.4% upside | |
| 2025-03-12 | H.C. WainwrightMitchell Kapoor | $75 | 192.2% upside | |
| 2024-11-13 | Cantor FitzgeraldRick Bienkowski | $83 | 223.3% upside | |
| 2024-10-15 | BTIGJustin Zelin | $91 | 254.5% upside | |
| 2024-10-15 | Johnson RiceGena Wang | $94 | 266.2% upside | |
| 2024-10-15 | BarclaysGena Wang | $94 | 266.2% upside | |
| 2024-10-08 | Redburn PartnersQize Ding | $86 | 235% upside | |
| 2024-06-17 | Piper SandlerEdward Tenthoff | $90 | 250.6% upside | |
| 2024-06-17 | Truist FinancialAsthika Goonewardene | $88 | 242.8% upside | |
| 2024-05-23 | Deutsche BankJames Shin | $60 | 133.7% upside | |
| 2024-05-17 | Morgan StanleyMatthew Harrison | $82 | 219.4% upside | |
| 2024-05-14 | RBC CapitalLeonid Timashev | $86 | 235% upside | |
| 2024-04-17 | ScotiabankGeorge Farmer | $65 | 153.2% upside | |
| 2024-04-03 | Cantor FitzgeraldRick Bienkowski | $82 | 219.4% upside | |
| 2024-03-14 | BMO CapitalKostas Biliouris | $90 | 250.6% upside | |
| 2022-12-06 | UBS | $66 | 157.1% upside | |